LivaNova PLC (LIVN) - Total Liabilities
Based on the latest financial reports, LivaNova PLC (LIVN) has total liabilities worth $1.30 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
LivaNova PLC - Total Liabilities Trend (1992–2025)
This chart illustrates how LivaNova PLC's total liabilities have evolved over time, based on quarterly financial data. Explore LIVN long-term investment intensity to see how much of total assets are deployed in long-term investments.
LivaNova PLC Competitors by Total Liabilities
The table below lists competitors of LivaNova PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BBVA Banco Frances SA
BA:BBAR
|
Argentina | AR$21.87 Trillion |
|
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
|
USA | $134.91 Million |
|
Jiangsu Pacific Quartz Co Ltd
SHG:603688
|
China | CN¥275.72 Million |
|
flatexDEGIRO AG
XETRA:FTK
|
Germany | €6.54 Billion |
|
Indorama Ventures PCL
BK:IVL
|
Thailand | ฿394.53 Billion |
|
Guangzhou Haige Communications Group Incorporated Co
SHE:002465
|
China | CN¥8.54 Billion |
|
Shenzhen Jove Enterprise Co. Ltd.
SHE:300814
|
China | CN¥1.61 Billion |
|
AMP Ltd
AU:AMP
|
Australia | AU$30.47 Billion |
Liability Composition Analysis (1992–2025)
This chart breaks down LivaNova PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see LivaNova PLC total assets.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how LivaNova PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for LivaNova PLC (1992–2025)
The table below shows the annual total liabilities of LivaNova PLC from 1992 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $1.41 Billion | +18.55% |
| 2024-12-31 | $1.19 Billion | +2.97% |
| 2023-12-31 | $1.15 Billion | +5.96% |
| 2022-12-31 | $1.09 Billion | +19.95% |
| 2021-12-31 | $906.31 Million | -29.78% |
| 2020-12-31 | $1.29 Billion | +25.54% |
| 2019-12-31 | $1.03 Billion | -1.71% |
| 2018-12-31 | $1.05 Billion | +51.90% |
| 2017-12-31 | $688.60 Million | +8.32% |
| 2016-12-31 | $635.70 Million | -14.93% |
| 2015-12-31 | $747.28 Million | +2029.51% |
| 2014-12-31 | $35.09 Million | 0.00% |
| 2013-12-31 | $35.09 Million | +1.79% |
| 2012-12-31 | $34.48 Million | +21.23% |
| 2011-12-31 | $28.44 Million | -21.04% |
| 2010-12-31 | $36.02 Million | +5.31% |
| 2009-12-31 | $34.20 Million | -27.96% |
| 2008-12-31 | $47.47 Million | -46.98% |
| 2007-12-31 | $89.53 Million | -40.72% |
| 2006-12-31 | $151.05 Million | +2.29% |
| 2005-12-31 | $147.67 Million | +534.88% |
| 2004-12-31 | $23.26 Million | -8.12% |
| 2003-12-31 | $25.32 Million | -8.55% |
| 2002-12-31 | $27.68 Million | +3.02% |
| 2001-12-31 | $26.87 Million | +6.95% |
| 2000-12-31 | $25.12 Million | +95.58% |
| 1999-12-31 | $12.85 Million | +100.72% |
| 1998-12-31 | $6.40 Million | +23.08% |
| 1997-12-31 | $5.20 Million | +36.84% |
| 1996-12-31 | $3.80 Million | +58.33% |
| 1995-12-31 | $2.40 Million | -17.24% |
| 1994-12-31 | $2.90 Million | +123.08% |
| 1993-12-31 | $1.30 Million | +18.18% |
| 1992-12-31 | $1.10 Million | -- |
About LivaNova PLC
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. The company operates in two segments, Cardiopulmonary and Neuromodulation. … Read more